Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Wallace

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
JAMA Surgery|February 22, 2023
Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant TherapyThomas J O'Keefe, Anne M Wallace
Clinical Breast Cancer|April 18, 2012
Breast cancer presenting within or adjacent to the breast implant capsule: a case series and clinical recommendationsChristopher A Tokin, Anne M Wallace
Breast Cancer Research and Treatment|June 13, 2020
Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosisThomas J O'Keefe, Anne M Wallace
Journal of Nuclear Medicine Technology|July 15, 2017
Use of <sup>99m</sup>Tc-Tilmanocept as a Single Agent for Sentinel Lymph Node Identification in Breast Cancer: A Retrospective Pilot StudyJonathan T Unkart, Anne M Wallace
Seminars in Oncology|August 10, 2002
The role of sentinel lymph node biopsy for melanomaJeannie Shen, Anne M Wallace, Michael Bouvet
Journal of Surgical Oncology|July 12, 2017
Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trialJonathan T Unkart, Ava Hosseini, Anne M Wallace
International Journal of Clinical Oncology|October 7, 2021
Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" diseaseThomas J O'Keefe, Olivier Harismendy, Anne M Wallace
The Breast Journal|March 3, 2018
Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancerJonathan T Unkart, James Proudfoot, Anne M Wallace
Chinese Clinical Oncology|March 15, 2023
Bilateral mastectomy associated with higher breast cancer mortality among patients with estrogen receptor positive progesterone receptor negative localized breast cancerThomas J O'Keefe, Olivier Harismendy, Anne M Wallace
Gland Surgery|March 14, 2022
Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all"Thomas J O'Keefe, Olivier Harismendy, Anne M Wallace
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
JAMA Surgery|February 22, 2023
Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant TherapyThomas J O'Keefe, Anne M Wallace
Clinical Breast Cancer|April 18, 2012
Breast cancer presenting within or adjacent to the breast implant capsule: a case series and clinical recommendationsChristopher A Tokin, Anne M Wallace
Breast Cancer Research and Treatment|June 13, 2020
Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosisThomas J O'Keefe, Anne M Wallace
Journal of Nuclear Medicine Technology|July 15, 2017
Use of <sup>99m</sup>Tc-Tilmanocept as a Single Agent for Sentinel Lymph Node Identification in Breast Cancer: A Retrospective Pilot StudyJonathan T Unkart, Anne M Wallace
Seminars in Oncology|August 10, 2002
The role of sentinel lymph node biopsy for melanomaJeannie Shen, Anne M Wallace, Michael Bouvet
Journal of Surgical Oncology|July 12, 2017
Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trialJonathan T Unkart, Ava Hosseini, Anne M Wallace
International Journal of Clinical Oncology|October 7, 2021
Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" diseaseThomas J O'Keefe, Olivier Harismendy, Anne M Wallace
The Breast Journal|March 3, 2018
Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancerJonathan T Unkart, James Proudfoot, Anne M Wallace
Chinese Clinical Oncology|March 15, 2023
Bilateral mastectomy associated with higher breast cancer mortality among patients with estrogen receptor positive progesterone receptor negative localized breast cancerThomas J O'Keefe, Olivier Harismendy, Anne M Wallace
Gland Surgery|March 14, 2022
Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all"Thomas J O'Keefe, Olivier Harismendy, Anne M Wallace
Pageof 10